¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : Á¦Ç°º°, Ç÷οì À¯Çüº°, ½ºÅ×ÀÌÁöº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, ÆÇ¸Å ä³Îº°, Áö¿ªº°
Global Enteral Feeding Formulas Market, By Product, By Flow Type, By Stage, By Indication, By End Use, By Sales Channel, By Geography
»óǰÄÚµå : 1741549
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,174,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,604,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,721,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀåÀº 2025³â¿¡´Â 69¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 131¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 9.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 69¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) : 9.50% ¿¹Ãø ±Ý¾×(2032³â) 131¾ï ´Þ·¯

°æÀå ¿µ¾çÁ¦´Â ÃæºÐÇÑ °æ±¸ ¼·Ã븦 ÇÒ ¼ö ¾ø´Â »ç¶÷ÀÇ À§, ½ÊÀÌÁöÀå, °øÀå¿¡ Á÷Á¢ Åõ¿©ÇÏ´Â ¿µ¾ç º¸Á¶ ½ÄǰÀÔ´Ï´Ù. °æÀå ¿µ¾çÁ¦¿¡´Â ´Ù¾çÇÑ À¯ÇüÀÌ ÀÖ½À´Ï´Ù. ´Ü¹éÁúÀ» ÁÖ ¿µ¾ç¼Ò·Î ÇÏ´Â °æÀå ¿µ¾çÁ¦´Â ź¼öÈ­¹° ¶Ç´Â Áö¹æÀÇ ¼·Ãë´Â ÃÖ¼ÒÇÑÀ¸·Î ¿µ¾ç º¸ÃæÀÌ ÇÊ¿äÇÑ »ç¶÷¿¡°Ô »ç¿ëµË´Ï´Ù. Ç¥ÁØ °æÀå ¿µ¾çÁ¦¿¡´Â ź¼öÈ­¹°, ´Ü¹éÁú ¹× Áö¹æÀÌ ±ÕÇü ÀÖ°Ô ¹èÇյǾî ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã³¹æÀº ÇÏ·ç¿¡ ÇÊ¿äÇÑ ¿µ¾çÀÇ ´ëºÎºÐÀ» ÃæÁ·Çϰí Àå±âÀûÀÎ »ç¿ë¿¡ ÀûÇÕÇÕ´Ï´Ù. Áúȯ ƯÀÌÀû ó¹æÀº ´ç´¢º´, ½ÅºÎÀü, °£Áúȯ µîÀÇ Æ¯Á¤ °Ç°­ »óÅ¿¡ ¸Â°Ô Á¶Á¤µÇ¾î ÀÖ½À´Ï´Ù. ½ÄÀ̼¶À¯ ÇÔÀ¯ Á¦Á¦´Â Á¤»óÀûÀÎ ÀåÀÇ ±â´ÉÀ» ÃËÁøÇϱâ À§ÇØ ¼ö¿ë¼º ½ÄÀ̼¶À¯ ¹× ºÒ¿ë¼º ½ÄÀ̼¶À¯°¡ ¹èÇյǾî ÀÖ½À´Ï´Ù.

°¢°¢ÀÇ À¯Çü¿¡´Â Àå´ÜÁ¡ÀÌ ÀÖ½À´Ï´Ù. ´Ü¹éÁú ±â¹ÝÀÇ Æ÷¹Ä·¯´Â °úµµÇÑ Ä®·Î¸®¸¦ ¼·ÃëÇÏÁö ¾Ê°í ´Ü¹éÁúÀÇ Çʿ䷮À» ÃæÁ·½ÃŰ´Â µ¥ µµ¿òÀÌ µÇÁö¸¸ ±ÕÇü ÀâÈù ¿µ¾çÀÌ ºÎÁ·ÇÕ´Ï´Ù. Ç¥ÁØ Ã³¹æÀº ±ÕÇü ÀâÈù ¿µ¾çÀ» Á¦°øÇÏÁö¸¸ Ưº°ÇÑ ½Ä»ç ¿ä±¸¸¦ ÃæÁ·½ÃŰÁö ¸øÇÒ ¼ö ÀÖ½À´Ï´Ù. Áúȯ ƯÀÌÀû Æ÷¹Ä·¯´Â ƯÁ¤ Áúȯ ƯÀ¯ÀÇ ¿µ¾ç ¿ä±¸¿¡ ´ëÀÀÇÏÁö¸¸ ºñ¿ëÀÌ ¸¹ÀÌ µì´Ï´Ù. ½ÄÀÌ ¼¶À¯¸¦ Æ÷ÇÔÇÑ Æ÷¹Ä·¯´Â ±ÔÄ¢ÀûÀÎ ¹èº¯À» µ½Áö¸¸ Á¡µµ°¡ ³ô°í Ä®·Î¸®°¡ ³ô½À´Ï´Ù. °³ÀÎÀÇ °Ç°­ »óÅÂ, ¿µ¾ç ¿ä±¸·® ¹× ³»¿ë¼º¿¡ µû¶ó ÀûÀýÇÑ Ã³¹æÀ» ¼±ÅÃÇØ¾ß ÇÕ´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â °æ±¸ ¼·Ãë·Î ¿µ¾çÀ» ¾òÀ» ¼ö ¾ø´Â ȯÀÚ¿¡°Ô ÃæºÐÇÑ ¿µ¾çÀ» È®º¸ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀåÀº °í·ÉÀÚ Àα¸ Áõ°¡, ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Á¶»ê¼ö Áõ°¡, ¼ºÀÎ »ïŰ´Â Àå¾ÖÀÇ ±ÞÁõ¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. À¯¿£ÀÇ ¿¹Ãø¿¡ µû¸£¸é 60¼¼ ÀÌ»óÀÇ ³ëÀÎ Àα¸´Â 2050³â±îÁö °ÅÀÇ µÎ ¹è·Î ´Ã¾î³ª û³â Àα¸¸¦ ´É°¡ÇÏ´Â ±Ô¸ð°¡ µÉ °ÍÀÔ´Ï´Ù. °í·ÉÀÚ´Â Ä¡¸Å³ª ¼ö¼ú ÈÄ ÇÕº´Áõ µî °æÀå ¿µ¾ç º¸Á¶¸¦ ÇÊ¿ä·Î ÇÏ´Â »óÅ¿¡ ºüÁö±â ½±½À´Ï´Ù. ¶ÇÇÑ °æÀå ¿µ¾çÁ¦¸¦ ÇÊ¿ä·Î ÇÏ´Â ¾Ï, ½Å°æÁúȯ, À§ÀåÁúȯ µî ¸¸¼ºÁúȯÀº ±¹Á¦ÀûÀ¸·Î Áõ°¡ Ãß¼¼¿¡ ÀÖ½À´Ï´Ù. À̰ÍÀº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ´ëü °ø±Þ ¹æ¹ýÀÇ ÀÌ¿ë °¡´É¼º, Æ©ºê¿¡ µû¸¥ °¨¿° À§Çè, Ư¼ö ó¹æÀÇ °íºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. À¯±â³ó, ºñÀ¯ÀüÀÚ º¯Çü(non-GMO), ¾Ë·¹¸£°Õ ÇÁ¸® ó¹æÀÇ °³¹ßÀº ½ÃÀå °ü°èÀÚ¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : Á¦Ç°º°(2020-2032³â)

Á¦6Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : Ç÷οì À¯Çüº°(2020-2032³â)

Á¦7Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : ½ºÅ×ÀÌÁöº°(2020-2032³â)

Á¦8Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : ÀûÀÀÁõº°(2020-2032³â)

Á¦9Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°(2020-2032³â)

Á¦10Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : ÆÇ¸Å ä³Îº°(2020-2032³â)

Á¦11Àå ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå : Áö¿ªº°(2020-2032³â)

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ¼½¼Ç

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Enteral Feeding Formulas Market is estimated to be valued at USD 6.94 Bn in 2025 and is expected to reach USD 13.1 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.94 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.50% 2032 Value Projection: USD 13.1 Bn

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics:

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study:

Global Enteral Feeding Formulas Market Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Enteral Feeding Formulas Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Enteral Feeding Formulas Market, By Product, 2020-2032, (US$ Bn)

6. Global Enteral Feeding Formulas Market, By Flow Type, 2020-2032, (US$ Bn)

7. Global Enteral Feeding Formulas Market, By Stage, 2020-2032, (US$ Bn)

8. Global Enteral Feeding Formulas Market, By Indication, 2020-2032, (US$ Bn)

9. Global Enteral Feeding Formulas Market, By End User, 2020-2032, (US$ Bn)

10. Global Enteral Feeding Formulas Market, By Sales Channel, 2020-2032, (US$ Bn)

11. Global Enteral Feeding Formulas Market, By Region, 2020-2032, (US$ Bn)

12. Competitive Landscape

13. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â